Bluebird Bio Stock Investor Sentiment

BLUE Stock  USD 3.73  0.13  3.37%   
About 64% of Bluebird Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Bluebird bio suggests that many traders are alarmed. The current market sentiment, together with Bluebird Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Bluebird bio stock news signals to limit their universe of possible portfolio assets.
  
a day ago at prnewswire.com         
LINGO RELEASES SPACE-THEMED STEM KITS AS FOUNDER PREPARES FOR HISTORIC ALL-FEMALE BLUE ORIGIN FLIGHT
prnewswire News
3 days ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS RECEIVES NCQA HEALTH EQUITY ACCREDITATION
prnewswire News
3 days ago at benzinga.com         
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In 286 Million Deal
benzinga news
3 days ago at finance.yahoo.com         
BMS to acquire longtime cell therapy partner 2seventy bio for 286m
Yahoo News
few days ago at thelincolnianonline.com         
Brokerages Set bluebird bio, Inc. Target Price at 44.14
news
over a week ago at news.google.com         
Bluebird bios chief commercial officer sells 1,959 in stock - Investing.com
Google News at Macroaxis
over a week ago at prnewswire.com         
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AND MASSCHALLENGE ANNOUNCE 2025 HEALTH EQUITY BUSINESS ACCEL...
prnewswire News
over a week ago at prnewswire.com         
Disposition of 921 shares by Andrew Obenshain of Bluebird Bio at 3.9194 subject to Rule 16b-3
prnewswire News
over a week ago at prnewswire.com         
AS CITIES SEEK NEW APPROACHES TO PUBLIC SAFETY, NEW BLUE IS A NATIONAL POLICE FELLOWSHIP CREATING IN...
prnewswire News
over a week ago at news.google.com         
bluebird bio stock slides for second day on buyout news - MSN
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Leiderman Elisabeth of 24900 shares of Bluebird Bio subject to Rule 16b-3
Macroaxis News
over two weeks ago at zacks.com         
Biotech Stock Roundup BLUE Down on Update, News From GILD, TRDA
zacks News
over two weeks ago at prnewswire.com         
MONSTER ENERGY LAUNCHES NEW ZERO SUGAR ULTRA BLUE HAWAIIAN
prnewswire News
over two weeks ago at news.google.com         
StockWatch Bluebird Bio Plunges on Buyout, as Gene Therapys Woes Grow - Genetic Engineering Biotechn...
Google News at Macroaxis
over two weeks ago at businesswire.com         
Shareholder Alert Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for it...
businesswire News
Far too much social signal, news, headlines, and media speculation about Bluebird Bio that are available to investors today. That information is available publicly through Bluebird media outlets and privately through word of mouth or via Bluebird internal channels. However, regardless of the origin, that massive amount of Bluebird data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bluebird Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bluebird Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bluebird Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bluebird Bio alpha.

Bluebird Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity